For the quarter ending 2026-03-31, ONCO has $14,832,086 in assets. $3,083,885 in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash | 3,716,072 | 5,220,654 | 836,556 | 283,515 |
| Accounts receivable, net | 43,725 | 296,866 | 2,552 | 12,156 |
| Inventories | 137,642 | 149,961 | 151,556 | 153,072 |
| Investor receivable, net | - | 50,000 | - | - |
| Prepaid expenses and other current assets | 431,915 | 349,293 | 311,362 | 481,788 |
| Total current assets | 4,329,354 | 6,066,774 | 1,302,026 | 930,531 |
| Property and equipment, net | 31,533 | 37,085 | 40,388 | 43,809 |
| Deferred offering costs | 225,000 | 225,000 | 150,000 | - |
| Operating right of use asset | 42,726 | 48,774 | 6,155 | 21,400 |
| Goodwill | 10,203,473 | 18,549,005 | 18,180,299 | 18,123,296 |
| Total assets | 14,832,086 | 24,926,638 | 19,678,868 | 19,119,036 |
| Accounts payable | 1,532,885 | 1,757,695 | 1,804,163 | 2,581,608 |
| Accrued expenses | 279,121 | 341,881 | 476,289 | 894,986 |
| Warrant liabilities | - | - | 12,815,000 | 53,113 |
| Notes payable | 247,196 | 0 | 160,267 | 8,731,571 |
| Operating lease liability, current | 24,415 | 24,412 | 6,155 | 21,400 |
| Subscription agreement liability related party | - | 0 | - | 0 |
| Contingent warrant liabilities | 24,978 | 26,590 | 53,149 | - |
| Due to shareholders | - | - | - | 409,510 |
| Derivative liabilities | 956,979 | 6,985,347 | 988,000 | - |
| Total current liabilities | 3,065,574 | 9,135,925 | 16,303,023 | 12,692,188 |
| Operating lease liability, net of current portion | 18,311 | 24,362 | - | - |
| Pension benefit obligation | - | 0 | - | 73,644 |
| Total liabilities | 3,083,885 | 9,160,287 | 16,303,023 | 12,765,832 |
| Due from shareholders | - | - | - | 0 |
| Series c redeemable preferred stock, 0.00001 par value, 10,000 shares authorized, 7 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 1,724 | 1,724 | 1,724 | 443,443 |
| Common stock, 0.00001 par value, 250,000,000 shares authorized at march 31, 2026 and december 31, 2025 2,755,184 and 312,028 shares issued at march 31, 2026 and december 31, 2025, respectively 2,755,154 and 311,998 shares outstanding at march 31, 2026 and december 31, 2025, respectively | 27 | 15 | 15 | 10 |
| Additional paid-in capital | 148,242,874 | 147,835,989 | 141,431,240 | 135,021,431 |
| Treasury stock, at cost 30 shares of common stock at march 31, 2026 and december 31, 2025 | 625,791 | 625,791 | 625,791 | 625,791 |
| Accumulated deficit | -135,429,433 | -131,214,558 | -136,884,245 | -128,100,543 |
| Accumulated other comprehensive loss | -441,200 | -231,028 | -547,098 | -385,346 |
| Preferred stock, value issued-Series DPreferred Stock | - | 0 | - | - |
| Preferred stock, value issued-Series EPreferred Stock | - | 0 | - | - |
| Due from shareholders | - | 0 | - | - |
| Total stockholders equity | 11,746,477 | 15,764,627 | 3,374,121 | 5,909,761 |
| Total liabilities, convertible preferred stock, and stockholders equity | 14,832,086 | 24,926,638 | 19,678,868 | 19,119,036 |
Onconetix, Inc. (ONCO)
Onconetix, Inc. (ONCO)